Walleye Capital’s AdaptHealth AHCO Stock Holding History

Walleye Capital’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,600	Closed	-$15.9K	–	4329
2025 Q4	$15.9K	Hold	1,600	–	–	﹤0.01%	4266
2025 Q3	$14.3K	Buy	1,600 +1,500	+1,500%	+$13.9K	﹤0.01%	4245
2025 Q2	$943	Buy	+100	New	+$882	﹤0.01%	4408

Other funds holding AHCO

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Walleye Capital's AHCO Position: Q1 2026 in Review

Walleye Capital sold out of AdaptHealth (AHCO) in Q1 2026, closing a stake of 184,966 shares — an estimated $1.84M sold.

Walleye Capital first reported a position in AHCO in Q1 2022 and held it in 6 quarters. The position peaked at $1.84M in Q4 2025. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

Walleye Capital reported no remaining AdaptHealth position as of Q1 2026 after selling out during the quarter.
Walleye Capital sold 184,966 AdaptHealth shares in Q1 2026, an estimated $1.84M.
Walleye Capital first reported a position in AdaptHealth in Q1 2022 and held it in 6 quarters.
Walleye Capital's AdaptHealth position peaked at $1.84M in Q4 2025.
241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.